Verona Pharma plc reported earnings results for the second quarter ended June 30, 2023. For the second quarter, the company reported net loss was USD 8.81 million compared to USD 17.77 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.04 USD | +0.33% | -5.79% | -39.44% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.44% | 98Cr | |
+12.30% | 12TCr | |
+12.15% | 11TCr | |
-8.14% | 2.34TCr | |
-0.29% | 2.21TCr | |
-9.28% | 1.83TCr | |
-41.70% | 1.66TCr | |
-15.33% | 1.6TCr | |
+5.80% | 1.4TCr | |
+28.03% | 1.17TCr |
- Stock Market
- Equities
- VRNA Stock
- News Verona Pharma plc
- Verona Pharma plc Reports Earnings Results for the Second Quarter Ended June 30, 2023